ECISBI.
| Study name | Efficacy of Clopidogrel on Incidence of Silent Brain Infarction (ECISBI) |
| Methods | Randomised controlled trial |
| Participants | 152 participants admitted for stroke/TIA, with indication for antiplatelet therapy as secondary prevention (decision independent of the study and based on individual clinical decision for each patient by the treating physician) |
| Interventions | Clopidogrel Aspirin |
| Outcomes | Primary outcome
Secondary outcome
|
| Starting date | 30 September 2021 |
| Contact information | Calin I Prodan, MD; 405‐456‐1479; calin.prodan@va.gov |
| Notes |